Sotatercept for the treatment of pulmonary arterial hypertension: PULSAR open-label extension

Autor: Marc Humbert, Vallerie McLaughlin, J. Simon R. Gibbs, Mardi Gomberg-Maitland, Marius M. Hoeper, Ioana R. Preston, Rogerio Souza, Aaron B. Waxman, Hossein-Ardeschir Ghofrani, Pilar Escribano Subias, Jeremy Feldman, Gisela Meyer, David Montani, Karen M. Olsson, Solaiappan Manimaran, Janethe de Oliveira Pena, David B. Badesch

Publikováno v: The European respiratory journal.

BackgroundIn participants with pulmonary arterial hypertension, 24 weeks of sotatercept resulted in a significantly greater reduction from baseline in pulmonary vascular resistance than placebo. This report characterises the longer-term safety and ef

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ded892a12b69bd74d92c82beb7be17f1
https://pubmed.ncbi.nlm.nih.gov/36041750

Relationship between right atrium area and right ventricular ejection fraction on magnetic resonance imaging: comparison with other prognostic markers in patients with pulmonary arterial hypertension

Autor: Yana L. R. Pallaoro, Stephan Altmayer, Fernanda B. Spilimbergo, Edson Marchiori, Marcelo M. Mello, Gisela Meyer, Daniela Cavalet Blanco, Guilherme Watte, Bruno Hochhegger

Publikováno v: Radiologia Brasileira
Radiologia Brasileira v.52 n.6 2019
Colégio Brasileiro de Radiologia e Diagnóstico por Imagem (CBR)
instacron:CBR
Radiologia Brasileira, Volume: 52, Issue: 6, Pages: 351-355, Published: 02 SEP 2019

Objective: To compare the right atrium (RA) area and right ventricular ejection fraction (RVEF) with other known prognostic markers in patients with pulmonary arterial hypertension (PAH). Materials and Methods: This was a retrospective study of 74 pa

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f117dc385904efe6d8535f71067d8ad
https://doi.org/10.1590/0100-3984.2018.0128

Late Breaking Abstract - Switching from PDE5i to riociguat in patients with PAH: The REPLACE study

Autor: Gérald Simonneau, Pavel Jansa, Stephan Rosenkranz, Hossein Ardeschir Ghofrani, Anton Vonk-Noordegraaf, Ekkehard Grünig, Hikmet Al-Hiti, Sung-A Chang, Frank Kleinjung, Karen Paraschin, David Langleben, James R. Klinger, Paul A. Corris, Gisela Meyer, Tomás Pulido, Andrew J. Peacock, Marius M. Hoeper, James R. White, Christian Meier, MiKyung Chang, Simon Gibbs, Vallerie V. McLaughlin, Raymond L. Benza, Jaquelina S. Ota-Arakaki, Dario Vizza

Publikováno v: Pulmonary hypertension.

Background: Pulmonary arterial hypertension (PAH) treatment guidelines recommend patients achieve/maintain a low-risk profile. Many patients treated with PAH-targeted therapy do not meet this treatment goal. Aim: Compare switching to riociguat (RIO)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::50239879a37706f47311c5b03fd0149f
https://doi.org/10.1183/13993003.congress-2020.3802

Effects of inspiratory muscle training on the sensation of dyspnea in patients with pulmonary hypertension group I and IV - Randomized controlled clinical trial

Autor: Fernanda B. Spilimbergo, Danilo C. Berton, Katya Rigatto, Guilherme Watte, Gisela Meyer, Fabricio Farias da Fontoura, Gabriela Roncato

Publikováno v: Physiotherapists.

The symptoms as fatigue and dyspnea are common in pulmonary hypertension (PH) and they impact in the exercise capacity and quality of life of patients. Also, the inspiratory muscle weak impairment potentiates these symptoms. Inspiratory muscle traini

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0b5327d51f5212662224e5e4d0afeba5
https://doi.org/10.1183/13993003.congress-2018.pa1718

Correlation between sympathovagal modulation and functional capacity in pulmonary arterial hypertension patients

Autor: Guilherme Watte, Walter Vargas, Gisela Meyer, Fabrício Farias da Fontoura, Fernanda B. Spilimbergo, Danilo C. Berton, Katya Rigatto, Gabriela Roncato, Karina Rabello Casali

Publikováno v: Pulmonary hypertension.

Background: Pulmonary arterial hypertension (PAH) is characterized by sympathovagal imbalance, endothelial dysfunction and progressive remodeling of the pulmonary vasculature that results in heart failure and impairs the functional capacity of patien

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::97841d7632e0e8c2663879cf91f82a7c
https://doi.org/10.1183/13993003.congress-2018.pa3327